Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Rivastigmine, in Alzheimer s disease

Grossberg G, Irwin P, Satlin A, et al Rivastigmine in Alzheimer s disease efficacy over two years. Am J Geriatr Psychiatry 12 420 31, 2004... [Pg.215]

Grossberg G, Desai A, Review of rivastigmine and its clinical applications in Alzheimer s disease and related disorders. Expert Opin Pharmacother 2 653-666, 2001. [Pg.420]

Spencer CM, Noble S, Rivastigmine—A Review of its use in Alzheimer s disease. Drugs Aging y33 -, 1998. [Pg.420]

V. Kaasinen, K. Nagren, T. Jarvenpaa, A. Roivainen, M. Yu, V. Oikonen, T. Kurki, J.O. Rinne, Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer s disease, J. Clin. Psychopharmacol. 22 (2002) 615-620. [Pg.83]

Bullock R, Touchon J, Bergman H, et al Rivastigmine and donepezil treatment in moderate to moderately severe Alzheimer s disease over a 2-year period. Curr Med Res Opin 21 1317-1327, 2005 Bums A, Rossor M, Hecker J, et al The effects of donepezil in Alzheimer s disease—results from a multinational trial. Dement Geriatr Cogn Disord 10 237-244, 1999... [Pg.213]

Small G, Kaufer K, Mendiondo MS, et al Cognitive performance in Alzheimer s disease patients receiving rivastigmine for up to 5 years. Int J Clin Pract 59 473 77, 2005... [Pg.218]

Rivastigmine, Donepezil, Tacrine etc. (used in Alzheimer s disease). ... [Pg.155]

Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, O Brien J, Everratt A, Sadler S, Maddison C, Lee L, Bannister C, Elvish R, Jacoby R. Quetiapine and rivastigmine and cognitive decline in Alzheimer s disease randomised double blind placebo controlled trial. BMJ 2005 330 874-7. [Pg.252]

Economic data in AD are increasing, and several studies have evaluated the cost benefits of medications. The Assessment of Health Economics in Alzheimer s Disease trial projected health and economic outcomes of AD patients treated with galantamine in the Netherlands over a 10-year period. Full-time patient care was predicted to be delayed by 10% in AD patients treated with galantamine. Studies with donepezil and rivastigmine have also predicted decreases in total costs of therapy and delayed nursing home placement. " ... [Pg.1170]

Gabelli C (2003). Rivastigmine An update on therapeutic efficacy in Alzheimer s disease and other conditions. Curr. Med. Res. Opin. 19 69-82. [Pg.225]

Bailey JA, Lahiri DK (2010) A novel effect of rivastigmine on presynaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer s disease. J Neurochem 112 843-853... [Pg.1357]

Corey-Bloom J, Anand R, Veach J, for the ENA 713 B352 Study Group (1998). A randomised trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild and moderately severe Alzheimer s disease. IntJGeriatrPsychopharmacolX, 55-65. [Pg.86]

Anticholinesterase A drug that inhibits the enzyme acetylcholinesterase, which normally inactivates acetylcholine at the synapse. The effect of an anticholinesterase (or cholinesterase inhibitor) is thus to prolong the duration of action of the neurotransmitter. An example is rivastigmine, used in the treatment of Alzheimer s disease. [Pg.237]

Wilkinson D, Passmore P, Bullock R, Hopker SW, Smith R, Potocnik FCV, Maud CM, Engelbrecht I, Ieni JR and Bahra RS (2002). A multinational, randomized, 12-week comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer s disease. International Journal of Clinical Practice, 56, 441-446. [Pg.287]

Farlow, M., Potkin, S., Koumaras, B., Veach, J., Mirski, D. (2003) Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-wk, Alzheimer s disease trial. Arch. Neurol, 60, 843-848. [Pg.339]

Traditionally, plants are a rich source of AChE inhibitors. People from the Caucasus used bulbs of snowdrops Galanthus sp.) to treat forgetfulness [25]. The active compound in this plant has been isolated and called galanthamine. Other plant-derived AChE inhibitors used for treatment of Alzheimer s disease include Huperzine A from Huperzia serrata and Rivastigmine (Excelon). The latter is a derivative from physostigmine isolated from the calabar bean, Physos-tigma vmmosum. [Pg.194]

See other pages where Rivastigmine, in Alzheimer s disease is mentioned: [Pg.35]    [Pg.38]    [Pg.35]    [Pg.38]    [Pg.150]    [Pg.213]    [Pg.40]    [Pg.217]    [Pg.489]    [Pg.1278]    [Pg.485]    [Pg.497]    [Pg.40]    [Pg.642]    [Pg.629]    [Pg.407]    [Pg.34]    [Pg.220]    [Pg.1173]    [Pg.210]    [Pg.411]    [Pg.667]    [Pg.283]    [Pg.78]    [Pg.187]    [Pg.228]    [Pg.358]    [Pg.349]    [Pg.155]    [Pg.280]    [Pg.69]    [Pg.46]    [Pg.676]   
See also in sourсe #XX -- [ Pg.519 , Pg.520 ]

See also in sourсe #XX -- [ Pg.730 ]

See also in sourсe #XX -- [ Pg.730 ]

See also in sourсe #XX -- [ Pg.1165 , Pg.1165 ]



SEARCH



In Alzheimer’s Disease

Rivastigmin

© 2024 chempedia.info